A multicenter phase II study of gemcitabine plus S-1 chemotherapy for advanced biliary tract cancer

被引：0
|
作者：
Arima, S. [1 ]
Shimizu, K. [2 ]
Okamoto, T. [3 ]
Toki, S. [4 ]
Kasuga, A. [1 ]
Kitamura, H. [1 ]
Takasu, A. [1 ]
Nagashima, F. [1 ]
Sugiyama, M. [5 ]
Furuse, J. [1 ]
机构：
[1] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan
[3] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
[4] Kyorin Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan
[5] Kyorin Univ, Sch Med, Dept Surg, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2620
引用
收藏
页码：S627 / S627
页数：1
相关论文
共 50 条
  • [1] A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer
    Arima, Shiho
    Shimizu, Kyoko
    Okamoto, Tomoyoshi
    Toki, Masao
    Suzuki, Yutaka
    Okano, Naohiro
    Naruge, Daisuke
    Kawai, Kirio
    Kobayashi, Takaaki
    Kasuga, Akiyoshi
    Kitamura, Hiroshi
    Takasu, Atuko
    Nagashima, Fumio
    Sugiyama, Masanori
    Furuse, Junji
    ANTICANCER RESEARCH, 2017, 37 (02) : 909 - 914
  • [2] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
  • [3] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Toda, Nobuo
    Yasuda, Ichiro
    Hasebe, Osamu
    Maetani, Iruru
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1101 - 1107
  • [4] Multicenter phase II study of gemcitabine (GEM) plus S-1 in patients (pts) with advanced biliary tract cancer (BTC)
    Sasaki, T.
    Isayama, H.
    Nakai, Y.
    Ito, Y.
    Togawa, O.
    Yagioka, H.
    Kogure, H.
    Yasuda, I.
    Hasebe, O.
    Maetani, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Suguru Mizuno
    Keisuke Yamamoto
    Hiroshi Yagioka
    Yoko Yashima
    Kazumichi Kawakubo
    Hirofumi Kogure
    Osamu Togawa
    Saburo Matsubara
    Yukiko Ito
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Nobuo Toda
    Minoru Tada
    Masao Omata
    Kazuhiko Koike
    Investigational New Drugs, 2012, 30 : 708 - 713
  • [6] Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Mizuno, Suguru
    Yamamoto, Keisuke
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Ito, Yukiko
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Toda, Nobuo
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 708 - 713
  • [7] A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
    Suzuki, Eiichiro
    Ikeda, Masafumi
    Okusaka, Takuji
    Nakamori, Shoji
    Ohkawa, Shinichi
    Nagakawa, Tatsuya
    Boku, Narikazu
    Yanagimoto, Hiroaki
    Sato, Tosiya
    Furuse, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1141 - 1146
  • [8] A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
    Eiichiro Suzuki
    Masafumi Ikeda
    Takuji Okusaka
    Shoji Nakamori
    Shinichi Ohkawa
    Tatsuya Nagakawa
    Narikazu Boku
    Hiroaki Yanagimoto
    Tosiya Sato
    Junji Furuse
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1141 - 1146
  • [9] A multicenter phase II of S-1 in gemcitabine-refractory biliary tract cancer
    Suzuki, E.
    Ikeda, M.
    Okusaka, T.
    Nakamori, S.
    Ohkawa, S.
    Nagakawa, T.
    Boku, N.
    Yamagimoto, H.
    Sugimori, K.
    Furuse, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Kim, Hyeong Su
    Kim, Ho Young
    Zang, Dae Young
    Oh, Ho Suk
    Jeon, Jang Yong
    Cho, Ji Woong
    Park, Choong Kee
    Kim, Jong Hyeok
    Kim, Min-Jeong
    Ha, Hong Il
    Kim, Jung Han
    Han, Boram
    Song, Hunho
    Kwon, Jung Hye
    Choi, Dae Ro
    Jung, Joo Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 711 - 718
12345